Telehealthcare for asthma

Susannah McLean, David Chandler, Ulugbek Nurmatov, Joseph L.Y. Liu, Claudia Pagliari, Josip Car, Aziz Sheikh

    Research output: Contribution to journalArticlepeer-review

    62 Citations (Scopus)
    344 Downloads (Pure)


    Healthcare systems internationally need to consider new models of care to cater for the increasing numbers of people with asthma. Telehealthcare interventions are increasingly being seen by policymakers as a potential means of delivering asthma care. We defined telehealthcare as being healthcare delivered from a distance, facilitated electronically and involving the exchange of information through the personalised interaction between a healthcare professional using their skills and judgement and the patient providing information.

    To assess the effectiveness of telehealthcare interventions in people with asthma.

    Search methods
    We searched in the following databases: Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL, AMED, and PsycINFO; this was supplemented by handsearching of respiratory journals. We also searched registers of ongoing and unpublished trials.
    Selection criteria

    We selected completed randomised controlled trials of telehealthcare initiatives aiming to improve asthma care.

    Data collection and analysis
    Two review authors independently appraised studies for inclusion and extracted data and performed meta-analyses. We analysed dichotomous variables to produce an odds ratio (OR) and continuous variables to produce a mean difference.

    Main results
    We included 21 trials in this review. The 21 included studies investigated a range of technologies aiming to support the provision of care from a distance. These included: telephone (n = 9); video-conferencing (n = 2); Internet (n = 2); other networked communications (n = 6); text Short Messaging Service (n = 1); or a combination of text and Internet (n = 1). Meta-analysis showed that these interventions did not result in clinically important improvements in asthma quality of life (minimum clinically important difference = 0.5): mean difference in Juniper's Asthma Quality of Life Questionnaire (AQLQ) 0.08 (95% CI 0.01 to 0.16). Telehealthcare for asthma resulted in a non-significant increase in the odds of emergency department visits over a 12-month period: OR 1.16 (95% CI 0.52 to 2.58). There was, however, a significant reduction in hospitalisations over a 12-month period: OR 0.21 (95% CI 0.07 to 0.61), the effect being most marked in people with more severe asthma managed predominantly in secondary care settings.

    Authors' conclusions
    Telehealthcare interventions are unlikely to result in clinically relevant improvements in health outcomes in those with relatively mild asthma, but they may have a role in those with more severe disease who are at high risk of hospital admission. Further trials evaluating the effectiveness and cost-effectiveness of a range of telehealthcare interventions are needed.

    This review is published as a Cochrane Review in the Cochrane Database of Systematic Reviews 2012, Issue 8. Cochrane Reviews are regularly updated as new evidence emerges and in response to comments and criticisms, and the Cochrane Database of Systematic Reviews should be consulted for the most recent version of the Review

    Original languageEnglish
    Article numberCD007717
    Pages (from-to)1-89
    Number of pages89
    JournalCochrane Database of Systematic Reviews
    Issue number8
    Publication statusPublished - Aug 2012


    • Telehealth
    • Asthma
    • eHealth
    • Cochrane systematic review
    • Meta-analysis


    Dive into the research topics of 'Telehealthcare for asthma'. Together they form a unique fingerprint.

    Cite this